FertilAI, an Israel-based company that develops AI-driven fertility treatment tools, has raised US$4.5 million.

The funding round was led by Longevity Venture Partners and Redseed, with additional participation from angel investors.

FertilAI offers AI solutions designed to assist doctors in clinical decision-making.

By 2024, more than 50 physicians worldwide are using FertilAI’s technology. This benefits over 20,000 patients.

The funds will be used for expanding market reach and hiring. Additionally, they aim to boost research and development.